Notice of first launch, interruption or termination of supply of a human drug
 DateHolder ▼CodeDrugDate fromSubject
 20.12.2019AbbVie s.r.o. (ABV)46784Zemplar 1 mikrogram mäkké kapsuly (cps mol 28x1 µg (blis.PVC/fluóropolymér/Al))12.12.2019R
 10.1.2020AbbVie s.r.o. (ABV)46784Zemplar 1 mikrogram mäkké kapsuly (cps mol 28x1 µg (blis.PVC/fluóropolymér/Al))10.1.2020O
 30.1.2023Ablynx NV (ABY)8964CCablivi 10 mg prášok a rozpúšťadlo na injekčný roztok (plv iol iol 1x10 mg + 1x1 ml solv. (liek.inj.skl. + striek.inj.napl.skl.))10.12.2022U
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)05194Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x100 ml/5 g (liek.inj.skl.))19.11.2019R
 26.6.2019Accord Healthcare Polska Sp. z o.o. (AOK)4516CClozapine Accord 100 mg tablety (tablety 50x100 mg (blis.Al/PVC/PVDC))4.6.2019R
 19.11.2019Accord Healthcare Polska Sp. z o.o. (AOK)05193Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x20 ml/1 g (liek.inj.skl.))22.11.2019R
 29.5.2020Accord Healthcare Polska Sp. z o.o. (AOK)20074Epirubicin Accord 2 mg/ml (sol ijf 1x5 ml/10 mg (liek.inj.skl.s bielym viečkom))4.6.2020R
 26.6.2019Accord Healthcare Polska Sp. z o.o. (AOK)0796BEtopozid Accord 20 mg/ml infúzny koncentrát (con inf 1x5 ml/100 mg (liek.inj.skl.))19.6.2019R
 28.5.2020Accord Healthcare Polska Sp. z o.o. (AOK)0796BEtopozid Accord 20 mg/ml infúzny koncentrát (con inf 1x5 ml/100 mg (liek.inj.skl.))28.5.2020O
 28.5.2020Accord Healthcare Polska Sp. z o.o. (AOK)05194Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok (sol ijf 1x100 ml/5 g (liek.inj.skl.))28.5.2020O
 9.1.2020Accord Healthcare Polska Sp. z o.o. (AOK)76909Midazolam Accord 5 mg/ml (sol ijf 1x10 ml/50 mg (amp.skl.))9.1.2020O
 9.1.2020Accord Healthcare Polska Sp. z o.o. (AOK)76908Midazolam Accord 5 mg/ml (sol ijf 10x3 ml/15 mg (amp.skl.))9.1.2020O
 22.1.2020Accord Healthcare Polska Sp. z o.o. (AOK)20076Epirubicin Accord 2 mg/ml (sol ijf 1x25 ml/50 mg (liek.inj.skl.s bielym/modrým viečkom))22.1.2020R
 1.7.2019Accord Healthcare Polska Sp. z o.o. (AOK)76909Midazolam Accord 5 mg/ml (sol ijf 1x10 ml/50 mg (amp.skl.))8.7.2019R
 23.9.2019Accord Healthcare Polska Sp. z o.o. (AOK)5715ACytarabine Accord 100 mg/ml injekčný a infúzny roztok (sol ijf 1x1 ml (liek.inj.skl.))15.10.2019R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)